相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BONLAC: A combinatorial proteomic technique to measure stimulus-induced translational profiles in brain slices
Heather Bowling et al.
NEUROPHARMACOLOGY (2016)
Dysregulation and restoration of translational homeostasis in fragile X syndrome
Joel D. Richter et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Selective Role of the Catalytic PI3K Subunit p110β in Impaired Higher Order Cognition in Fragile X Syndrome
Christina Gross et al.
CELL REPORTS (2015)
Increased Expression of the PI3K Enhancer PIKE Mediates Deficits in Synaptic Plasticity and Behavior in Fragile X Syndrome
Christina Gross et al.
CELL REPORTS (2015)
Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies
Toby A. Eyre et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours
Anthony Tolcher et al.
EUROPEAN JOURNAL OF CANCER (2014)
Identification of Fragile X Syndrome Specific Molecular Markers in Human Fibroblasts: A Useful Model to Test the Efficacy of Therapeutic Drugs
Daman Kumari et al.
HUMAN MUTATION (2014)
Requirement of Mammalian Target of Rapamycin Complex 1 Downstream Effectors in Cued Fear Memory Reconsolidation and Its Persistence
Thu N. Huynh et al.
JOURNAL OF NEUROSCIENCE (2014)
Genetic Removal of Matrix Metalloproteinase 9 Rescues the Symptoms of Fragile X Syndrome in a Mouse Model
Harpreet Sidhu et al.
JOURNAL OF NEUROSCIENCE (2014)
Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant
Andreea S. Pop et al.
PSYCHOPHARMACOLOGY (2014)
Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes
Christos G. Gkogkas et al.
CELL REPORTS (2014)
Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology
Tsuyoshi Udagawa et al.
NATURE MEDICINE (2013)
The translation of translational control by FMRP: therapeutic targets for FXS
Jennifer C. Darnell et al.
NATURE NEUROSCIENCE (2013)
Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
Emily K. Osterweil et al.
NEURON (2013)
The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design
Sylvain Couty et al.
ONCOTARGET (2013)
Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
Michael R. Santoro et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
Brian Magnuson et al.
BIOCHEMICAL JOURNAL (2012)
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome
C. A. Hoeffer et al.
GENES BRAIN AND BEHAVIOR (2012)
Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice
Aditi Bhattacharya et al.
NEURON (2012)
Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
Aubin Michalon et al.
NEURON (2012)
Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)
Laura R. Pearce et al.
BIOCHEMICAL JOURNAL (2010)
Excess Phosphoinositide 3-Kinase Subunit Synthesis and Activity as a Novel Therapeutic Target in Fragile X Syndrome
Christina Gross et al.
JOURNAL OF NEUROSCIENCE (2010)
Dysregulation of mTOR Signaling in Fragile X Syndrome
Ali Sharma et al.
JOURNAL OF NEUROSCIENCE (2010)
Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
Emily K. Osterweil et al.
JOURNAL OF NEUROSCIENCE (2010)
mTOR signaling: At the crossroads of plasticity, memory and disease
Charles A. Hoeffer et al.
TRENDS IN NEUROSCIENCES (2010)
Translational Control of Long-Lasting Synaptic Plasticity and Memory
Mauro Costa-Mattioli et al.
NEURON (2009)
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Colin Selman et al.
SCIENCE (2009)
分享论文
